Skin-resident antigen-presenting cells: instruction manual for vaccine development.
about
Tissue signatures influence the activation of intrahepatic CD8(+) T cells against malaria sporozoitesDendritic cell-based vaccine efficacy: aiming for hot spotsTattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7.Classification of Laser Vaccine AdjuvantsPotential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform.Semiconductor diode laser device adjuvanting intradermal vaccine.Following the Preclinical Data: Leveraging the Abscopal Effect More Efficaciously.Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA VaccinationCurrent opportunities and challenges in intradermal vaccination.Human cytomegalovirus-based immunotherapy to treat glioblastoma: Into the future.Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccinesHuman skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors.Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice.Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid.Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.A systematic approach to the development of a safe live attenuated Zika vaccine.Approaches to Improve Chemically Defined Synthetic Peptide Vaccines.Protection against neonatal enteric colibacillosis employing E. Coli-derived outer membrane vesicles in formulation and without vitamin D3.
P2860
Q27026412-A5E638B1-977B-4535-8A66-00AF71E47512Q28082680-7F982426-DCD3-4817-8864-B4A07BEC2452Q35826994-031D1440-A6EB-4CE9-8B7F-F8ECE6B7A9E8Q35996738-CFDD2256-1842-4561-887C-9BA60E5BA8E0Q36056484-A961B4EF-3125-4C75-B4EF-E78D25F132B9Q36330880-3A9E0EF1-6989-4282-8325-DB1D9411AEEDQ36356635-05986353-88D4-49C8-9676-68C2C4F748D8Q37277900-1B4D88D9-71C8-4A7A-9E68-FAAAC0275F4AQ38604987-5FF44AF4-A676-4B38-A37F-ACD3189EAA0AQ38809194-E8170CB2-6D5B-484A-AF49-93059D6A0063Q39448911-4B533D87-50A1-4BEF-A273-4A374357EBF9Q42106951-5B5AADA9-C2D5-435F-8F5F-EDEACFCDE4FDQ47554106-A75FF081-75C1-4309-A086-7AD3104D0ABAQ47708661-31F4FD02-0716-40A6-AF5D-66A522CAA686Q50863077-4DD640C5-85C4-4550-B12C-38AF07A6438DQ51336360-CE6948FE-8F32-4D5F-924D-1CFD0186CD86Q54961397-2EADBC73-676A-4962-8157-FCF7FE453183Q55262720-0D10AA64-B876-4437-93E5-69232A573402
P2860
Skin-resident antigen-presenting cells: instruction manual for vaccine development.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Skin-resident antigen-presenting cells: instruction manual for vaccine development.
@en
type
label
Skin-resident antigen-presenting cells: instruction manual for vaccine development.
@en
prefLabel
Skin-resident antigen-presenting cells: instruction manual for vaccine development.
@en
P2093
P2860
P356
P1476
Skin-resident antigen-presenting cells: instruction manual for vaccine development.
@en
P2093
Cynthia M Fehres
Wendy W J Unger
Yvette van Kooyk
P2860
P356
10.3389/FIMMU.2013.00157
P577
2013-06-20T00:00:00Z